Skip to main content



Local Cdiff information for Massachusetts

Massachusetts

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Massachusetts.



Local Cdiff information for Massachusetts

Massachusetts

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Massachusetts.

Providers

Dr. Alan C. Moss, MD,

FACG, FEBG
Interim Chief, Department of Gastroenterology
Boston Medical Center
725 Albany Street, 6th Floor
Boston, 02118
(617) 638-6525
EMAIL DR. MOSS >
FMT Provider: Yes
VISIT WEBSITE >

Dr. Stacy A. Kahn, MD

Director, Fecal Microbiota Transplantation; Attending Physician, Division of Gastroenterology, Hepatology and Nutrition
Boston Children’s Hospital
300 Longwood Avenue
Boston, 02115
617-355-6058
FMT Provider: Yes
VISIT WEBSITE >

Dr. Razvan Arsenescu, MD, PhD

90 Libbey Industrial Parkway
Weymouth, 02189
781-682-0630
EMAIL DR. ARSENESCU >
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 2115
Hospital Onset: 2115
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.78
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: Yes
LTC Facility Data Publicly Reported: No
Law/Regulation: MGL. c .111D, s. 6
STATUTE >

State Contact

Eileen McHale
Patient Safety Ombudsman
Massachusetts Department of Public Health
Betsy Lehman Center for Patient Safety and Medical Error Reduction
99 Chauncy Street
Boston, 2111
(617) 753-7324
EMAIL EILEEN MCHALE >

CLINICAL TRIALS

Outcomes and Data Collection for FMT

Official Title: Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
Trial No. NCT03562741
Type: Interventional
Recruitment: Recruiting
Sponsor: Kruna Patel, University of Massachusetts, Worcester
Contact: Anne Foley
EMAIL
Gender: All
Age: 16 years and older

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

Pre-emptive Prevention

Official Title: A Pre-emptive Prevention Bundle for Patients at High Risk for Hospital-onset Clostridioides Difficile
Trial No. NCT058389904
Type: Interventional
Recruitment: Recruiting
Sponsor: Brigham and Women’s Hospital
Contact: Meghan A Baker, MD, SCD
617-732-8881
EMAIL
Gender: All
Age: 18 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.

BEETHOVEN

Official Title: A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER
Trial No. NCT07282665
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: See trial website for site-specific contacts
Gender: All
Age: 65 Years and older

PRISM

Official Title: A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above
Trial No. NCT07285213
Type: Interventional
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: See trial website for site-specific contacts
Gender: All
Age: 18 Years and older